Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.78 |
| ▸ | MAPT | P10636 | 4/20 | 0.78 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.78 |
| ▸ | TP53 | P04637 | 3/20 | 0.78 |
| ▸ | TSHR | P16473 | 3/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.78 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.78 |
| ▸ | THPO | P40225 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.65 |
| ▸ | HRH1 | P35367 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyryl-Carnitine SCHEMBL886918 | 1.00 | MEN1 (0.78) | MEN1KMT2AMAPTSLC25A20TP53 | |
| Butyryl-Carnitine SCHEMBL237454 | 1.00 | MEN1 (0.78) | MEN1KMT2AMAPTSLC25A20TP53 | |
| Butyryl-Carnitine SCHEMBL28712508 | 0.98 | MEN1 (0.76) | MEN1KMT2AMAPTSLC25A20TP53 | |
| Butyryl-Carnitine SCHEMBL28900550 | 0.94 | MEN1 (0.70) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL7048157 | 0.91 | MEN1 (0.77) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL288262 | 0.90 | MEN1 (0.89) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL886920 | 0.90 | MEN1 (0.89) | MEN1KMT2AMAPTSLC25A20TP53 | |
| Butyryl-Carnitine SCHEMBL6469306 | 0.90 | MEN1 (0.76) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL8977796 | 0.89 | MEN1 (0.97) | MEN1KMT2AMAPTSLC25A20TP53 | |
| SCHEMBL235082 | 0.89 | MEN1 (0.97) | MEN1KMT2AMAPTSLC25A20TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11313866-B2 | Method of diagnosing and treating asphyxia | INFANDX AG (DE) | 2022-04-26 | — | — | US | disclosed |
| EP-2249161-B1 | Method of diagnosing asphyxia | INFANDX AG (DE) | 2020-05-13 | — | — | EP | disclosed |
| US-20180011111-A1 | Method of Diagnosing and Treating Asphyxia | INFANDX AG (DE) | 2018-01-11 | — | — | US | disclosed |
| US-9791459-B2 | Method of diagnosing and treating asphyxia | INFANDX AG (DE) | 2017-10-17 | — | — | US | disclosed |
| EP-2427773-B1 | METHOD OF DIAGNOSING ASPHYXIA | INFANDX AG (DE) | 2016-07-06 | — | — | EP | disclosed |
| EP-2449488-B1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2015-01-14 | — | — | EP | disclosed |
| CN-102943106-A | Substrates and internal standards for mass spectroscopy detection | PERKINELMER LAS INC | 2013-02-27 | — | — | CN | disclosed |
| US-20120208282-A1 | Method For Normalization in Metabolomics Analysis Methods with Endogenous Reference Metabolites. | BIOCRATES LIFE SCIENCES AG | 2012-08-16 | — | — | US | disclosed |
| US-20120136581-A1 | Method of Diagnosing Asphyxia | BIOCRATES LIFE SCIENCES AG (AT) | 2012-05-31 | — | — | US | disclosed |
| EP-2449488-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES Life Sciences AG (AT) | 2012-05-09 | — | — | EP | disclosed |
| EP-2427773-A1 | METHOD OF DIAGNOSING ASPHYXIA | Keller, Matthias (DE) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011000753-A1 | METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES | BIOCRATES LIFE SCIENCES AG (AT) | 2011-01-06 | — | — | WO | disclosed |
| EP-2270699-A1 | Method for normalization in metabolomics analysis methods with endogenous reference metabolites | BIOCRATES Life Sciences AG (AT) | 2011-01-05 | — | — | EP | disclosed |
| WO-2010128054-A1 | METHOD OF DIAGNOSING ASPHYXIA | BIOCRATES LIFE SCIENCES AG (AT) | 2010-11-11 | — | — | WO | disclosed |
| CN-101426926-A | Substrate and internal standard for mass spectrometry detection | PERKINELMER LAS INC (US) | 2009-05-06 | — | — | CN | disclosed |
| EP-1999270-A2 | SUBSTRATES AND INTERNAL STANDARDS FOR MASS SPECTROSCOPY DETECTION | Perkinelmer Las, Inc. (US) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106816-A2 | SUBSTRATES AND INTERNAL STANDARDS FOR MASS SPECTROSCOPY DETECTION | PERKINELMER LAS, INC. (US) | 2007-09-20 | — | — | WO | disclosed |